Bangaruswamy V Kumar, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 800 W Highway 71, Marble Falls, TX 78654 Phone: 830-201-7100 |
News Archive
Antiva Biosciences, Inc. (formerly Hera Therapeutics), a biopharmaceutical company developing antiviral therapeutics, today announced that it has raised $16 million in a Series B financing, its first institutional round.
BeaconEquity.com announces an investment report featuring PURE Bioscience. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.
Scientists at the University of Sheffield, working in collaboration with drug and vaccine developer Kymab Ltd, Cambridge, have identified a novel antibody that has the potential to become a new treatment for pulmonary arterial hypertension (PAH).
Ipilimumab used in combination with paclitaxel/carboplatin for stage IIIb/IV non-small cell lung cancer showed superior results in progression free survival when compared to paclitaxel/carboplatin alone, according to research presented at the 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology. This symposium is sponsored by the American Society for Radiation Oncology (ASTRO), the American Society of Clinical Oncology (ASCO), the International Association for the Study of Lung Cancer (ISLAC) and the University of Chicago.
› Verified 7 days ago